| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/26/2007 | US20070092876 Method and system for cell and/or nucleic acid molecules isolation |
| 04/26/2007 | US20070092875 Map2k6 as modifier of branching morphogenesis and methods of use |
| 04/26/2007 | US20070092874 Plasma or serum marker and process for detection of cancer |
| 04/26/2007 | US20070092873 Digital identification of genetic materials and methods for acquiring data for it |
| 04/26/2007 | US20070092872 Apparatus and method for sequencing a nucleic acid |
| 04/26/2007 | US20070092871 Microarray for pathogen identification |
| 04/26/2007 | US20070092870 Detection of biomolecules |
| 04/26/2007 | US20070092869 Spike-in controls and methods for using the same |
| 04/26/2007 | US20070092868 Liquid crystal cassette |
| 04/26/2007 | US20070092867 Application using non-covalent bond between a cucurbituril derivative and a ligand |
| 04/26/2007 | US20070092866 Avian adenoassociated virus and uses thereof |
| 04/26/2007 | US20070092865 Detection and characterization of psychoactives using parallel multi-site assays in brain tissue |
| 04/26/2007 | US20070092864 Treatment planning methods, devices and systems |
| 04/26/2007 | US20070092863 Decalcify a large bone block usinga calcium dissolving agent of ethylenediaminetetraacetic acid or formic acid; and, galactose and palmitic acid bubble-forming agent for generating microbubbles when the bone-decalcifying agent is exposed to ultrasonic vibration; medical diagnosis; surgercal grafting |
| 04/26/2007 | US20070092862 Flow sensors for penile tumescence |
| 04/26/2007 | US20070092861 Environments that maintain function of primary liver cells |
| 04/26/2007 | US20070092577 Dietary calcium for reducing the production of reactive oxygen species |
| 04/26/2007 | US20070092538 Immunogenic reagents from west nile virus |
| 04/26/2007 | US20070092534 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 04/26/2007 | US20070092529 Using gene encoding transmembrane ptorein |
| 04/26/2007 | US20070092525 Polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual |
| 04/26/2007 | US20070092522 Contacting a monoclonal antibody with a soluble antigen; cancer vaccines |
| 04/26/2007 | US20070092519 Method for diagnosing chronic myeloid leukemia |
| 04/26/2007 | US20070092514 Novel secreted immunomodulatory proteins and uses thereof |
| 04/26/2007 | US20070092511 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 04/26/2007 | US20070092503 Human alkaline sphingomyelinase and use thereof |
| 04/26/2007 | US20070092498 Methods of diagnosing, prognosing and treating breast cancer |
| 04/26/2007 | US20070092488 Methods of treating idiopathic pulmonary fibrosis |
| 04/26/2007 | US20070092484 MCP-1 splice variants and methods of using same |
| 04/26/2007 | US20070092448 Inhibitor screening method and atopic dermatitis-like symptom inducing method which utilizes induction of production of interleukin 18 by keratinocyte and utilization of same |
| 04/26/2007 | US20070092444 Inhibition of inward sodium currents in cancer |
| 04/26/2007 | US20070089987 Systems and methods for blood glucose sensing |
| 04/26/2007 | DE19612356B4 Optischer Nachweis von Hybridisierungs-Signalen Optical detection of hybridization signals |
| 04/26/2007 | DE112005001143T5 System und Verfahren zum Gruppieren von Vorläufer- und Fragmentionen unter Verwendung von Chromatogrammen ausgewählter Ionen System and method for grouping precursor and fragment ions using selected ion chromatograms |
| 04/26/2007 | DE112005000590T5 Polynukleotidphosphorylase (PNPase) als Ziel für Herbizide Polynucleotide phosphorylase (PNPase) as a target for herbicides |
| 04/26/2007 | DE102005050933A1 Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen Concerning invention expression profiles for the prediction of septic conditions |
| 04/26/2007 | DE102005050834A1 Use of long chain azo dye as blotter for fluorescent based detection reactions and as dye for optical detection e.g. in qualitative and quantitative determination procedure e.g. immune tests and hybridization procedure |
| 04/26/2007 | DE102005050833A1 Use of long chain azo dye as blotter for fluorescent based detection reactions and as dye for optical detection e.g. in qualitative and quantitative determination procedure e.g. immune tests and hybridization procedure |
| 04/26/2007 | DE102005049800A1 Verfahren zur Auffindung von Inhibitoren des Epstein-Barr-Virus-induzierten Gens 3 (EBI 3) und deren Verwendungen bei der Behandlung von metastasierenden Tumoren und allergischem Asthma A method for identifying inhibitors of the Epstein-Barr virus induced gene 3 (EBI 3) and their uses in the treatment of metastatic tumors and allergic asthma |
| 04/26/2007 | DE102005049537A1 New cyclic peptides, useful e.g. as antibiotics and in cosmetics, are prepared by synthesis of linear peptide from selected starter amino acid then cyclization |
| 04/26/2007 | DE102005029809B4 Vorrichtung und Verfahren zur Aufbereitung einer Probe für eine Analyse und Vorrichtung und Verfahren zur Analyse einer Probe Apparatus and method for preparing a sample for analysis and a device and method for analyzing a sample |
| 04/26/2007 | DE102004004924B4 A141S-und G399S-Mutation im Omi/HtrA2-Protein bei Morbus Parkinson A141S and G399S mutation in the Omi / HtrA2 protein in Parkinson's disease |
| 04/26/2007 | CA2626757A1 Methods and kits for analyzing genetic material of a fetus |
| 04/26/2007 | CA2626604A1 Method and apparatus for correlating levels of biomarker products with disease |
| 04/26/2007 | CA2626533A1 Method for the isolation of mrna from formalin fixed, paraffin-embedded tissue |
| 04/26/2007 | CA2626361A1 Pharmaceutical compositions and diagnostic methods for inflammatory skin diseases, disorders or conditions |
| 04/26/2007 | CA2626094A1 Repair of nucleic acids for improved amplification |
| 04/26/2007 | CA2625971A1 Minimal bacterial genome |
| 04/26/2007 | CA2625489A1 In situ assembly of protein microarrays |
| 04/26/2007 | CA2625414A1 Compositions and methods to detect legionella pneumophila nucleic acid |
| 04/26/2007 | CA2625169A1 Methods of reducing repeat-induced silencing of transgene expression and improved fluorescent biosensors |
| 04/26/2007 | CA2624931A1 Therapeutic agent |
| 04/26/2007 | CA2624290A1 Selective posttranslational modification of phage-displayed polypeptides |
| 04/26/2007 | CA2607056A1 Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| 04/26/2007 | CA2592065A1 Glp-1 agonists, compositions, methods and uses |
| 04/26/2007 | CA2588787A1 Optoelectronic detection system |
| 04/26/2007 | CA2562740A1 Methods for identifying agents that modulate gpr105 activity |
| 04/26/2007 | CA2556635A1 Methods for diagnosing and characterizing breast cancer and susceptibility to breast cancer |
| 04/25/2007 | EP1777519A1 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 04/25/2007 | EP1777512A2 Electrophoretic cartridge for detecting biopolymers |
| 04/25/2007 | EP1777301A2 Analysis of microRNA |
| 04/25/2007 | EP1777300A1 Organic salt additives for nucleic acid amplification |
| 04/25/2007 | EP1777299A1 Combination of optical mapping with ordered restriction maps |
| 04/25/2007 | EP1777298A1 Multiplexed solid-phase nucleic acid amplification assay |
| 04/25/2007 | EP1777297A1 Fluorescent substrates for detecting organophosphatase enzyme activity |
| 04/25/2007 | EP1777293A1 Transferrin receptor genes of Moraxella |
| 04/25/2007 | EP1777291A1 Method for the isolation of mRNA from formalin fixed, paraffin-embedded tissue |
| 04/25/2007 | EP1776954A2 The use of inhibitors of the renin-angiotensin system for the treatment of stroke |
| 04/25/2007 | EP1776591A1 Diagnostic and therapeutic use of a plasma membrane atpase |
| 04/25/2007 | EP1776482A2 Log-linear amplification |
| 04/25/2007 | EP1776481A2 Diagnosis and treatment of kawasaki disease and coronavirus infection |
| 04/25/2007 | EP1776480A2 Markers and methods for prenatal screening of chromosomal aberrations |
| 04/25/2007 | EP1776479A2 Sequencing of modified nucleic acid molecules |
| 04/25/2007 | EP1776478A1 Cancer treatment resistance and agents modulating such resistance |
| 04/25/2007 | EP1776477A2 Method for rapid identification of microorganisms |
| 04/25/2007 | EP1776476A2 Complex able to detect an analyte, method for its preparation and uses thereof |
| 04/25/2007 | EP1776475A2 Tumor marker for use in the diagnosis of carcinomas and/or metastases originating therefrom |
| 04/25/2007 | EP1776474A2 Detection of oligonuleotides by dual hybridization |
| 04/25/2007 | EP1776473A1 Microfluidic device for performing a plurality of reactions and uses thereof |
| 04/25/2007 | EP1776472A2 Methods for predicting methotrexate polyglutamate levels using pharmacogenetics |
| 04/25/2007 | EP1776471A2 Method of measuring cancer susceptibility |
| 04/25/2007 | EP1776469A2 Solid-fluid composition and uses thereof |
| 04/25/2007 | EP1776468A1 Method of assaying fad synthetase |
| 04/25/2007 | EP1776467A1 Method for determining the amount of template nucleic acid present in a sample |
| 04/25/2007 | EP1776466A1 Methods and kits for assaying myeloperoxidase by means of enzymatic glycolate-glyoxylate cycling reactions |
| 04/25/2007 | EP1776465A2 Test media and quantitative or qualitative method for identification and differentiation of biological materials in a test sample |
| 04/25/2007 | EP1776464A1 Analyte test system for determining the concentration of an analyte in a physiological or aqueous fluid |
| 04/25/2007 | EP1776456A2 Isolated chimeric proteins of modified lumazine synthase |
| 04/25/2007 | EP1776449A2 Magnetic device for isolation of cells and biomolecules in a microfluidic environment |
| 04/25/2007 | EP1776380A2 Gfp-snap25 fluorescence release assay for botulinum toxin protease activity |
| 04/25/2007 | EP1776035A2 Non-invasive glucose measurement |
| 04/25/2007 | EP1678489B1 Method of reducing the effect of direct interference current in an electrochemical test strip |
| 04/25/2007 | EP1668159A4 Detection of 13q14 chromosomal alterations |
| 04/25/2007 | EP1644734A4 Method for assaying protein-protein interaction |
| 04/25/2007 | EP1589814A4 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications |
| 04/25/2007 | EP1587951A4 Substrate detection assay |
| 04/25/2007 | EP1570083A4 Identification of genes involved in angiogenesis, and development of an angiogenesis diagnostic chip to identify patients with impaired angiogenesis |
| 04/25/2007 | EP1565580A4 Compositions, methods and kits for polynucleotide amplification reactions and microfluidic devices |
| 04/25/2007 | EP1549955B1 Method for detecting analytes |
| 04/25/2007 | EP1549769A4 Gene expression profiling from ffpe samples |